Assessing Agreement between miRNA Microarray Platforms

Niccolò P Bassani1, Federico Ambrogi2, Elia M Biganzoli1

  • 1Department of Clinical Sciences and Community Health, University of Milan, Via Vanzetti 5 20133, Milano (MI), Italy.

Insights

This study introduces a modified Bland-Altman plot to evaluate agreement between miRNA microarray platforms. The method revealed good concordance for Agilent and Illumina, but poor-to-moderate agreement for Affymetrix.

Area of Science:

  • Biotechnology
  • Genomics
  • Medical Diagnostics

Background:

  • MicroRNA (miRNA) microarrays are crucial for understanding disease mechanisms.
  • Limited studies assess concordance between miRNA microarray platforms considering measurement error.

Purpose of the Study:

  • To propose and validate a modified Bland-Altman plot for assessing agreement between miRNA microarray platforms.
  • To evaluate the concordance of Affymetrix, Agilent, and Illumina miRNA platforms.

Main Methods:

  • Profiling of a renal tumor cell line and normal human tissues on three miRNA platforms (Affymetrix, Agilent, Illumina) in triplicate.
  • Assessment of intra-platform reliability using concordance correlation coefficients (CCC and OCCC).
  • Application of a modified Bland-Altman plot to analyze inter-platform agreement, accounting for measurement error and bias.

Main Results:

  • All platforms demonstrated moderate-to-good intra-platform repeatability (CCC and OCCC).
  • Modified Bland-Altman analysis showed good concordance for Agilent and Illumina platforms.
  • Affymetrix platform exhibited poor-to-moderate agreement between samples.

Conclusions:

  • The modified Bland-Altman plot effectively assesses agreement between miRNA microarray platforms, accounting for measurement error.
  • Agilent and Illumina platforms show better concordance compared to Affymetrix for miRNA profiling.
  • The method is adaptable for evaluating concordance across various array-based technologies.